share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144:擬議出售證券
美股sec公告 ·  05/03 03:18
牛牛AI助理已提取核心訊息
Teladoc Health, Inc. officer Raman-Tangella Vidya is set to sell 3,691 shares of common stock on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $46,831.78, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by the officer, who sold a total of 8,727 shares in the past three months, generating gross proceeds of $145,924.45.
Teladoc Health, Inc. officer Raman-Tangella Vidya is set to sell 3,691 shares of common stock on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $46,831.78, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by the officer, who sold a total of 8,727 shares in the past three months, generating gross proceeds of $145,924.45.
正如在最近的一份文件中宣佈的那樣,Teladoc Health, Inc.高管Raman-Tangella Vidya定於2024年2月5日出售3691股普通股。這些股票的總市值爲46,831.78美元,作爲發行人補償的一部分,於2024年1月5日通過限制性股票歸屬收購。該交易遵循了該高管最近的銷售記錄,他在過去三個月中共出售了8,727股股票,總收益爲145,924.45美元。
正如在最近的一份文件中宣佈的那樣,Teladoc Health, Inc.高管Raman-Tangella Vidya定於2024年2月5日出售3691股普通股。這些股票的總市值爲46,831.78美元,作爲發行人補償的一部分,於2024年1月5日通過限制性股票歸屬收購。該交易遵循了該高管最近的銷售記錄,他在過去三個月中共出售了8,727股股票,總收益爲145,924.45美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。